Development and Dissolution Velocity Studies of an Oral Albendazole Nanocrystal Solid Formulation

REFERENCES

• Cook , G. C. 1990 . Use of benzimidazole chemotherapy in human helminthiases: Indications and efficacy . Parasitol. Today , 6 ( 4 ) : 133 – 136 .
   Google Scholar
• Wen , H. , New , R. R. C. and Craig , P. S. 1993 . Diagnosis and treatment of human hydatidosis . Br. J. Clin. Pharmacol. , 35 : 565 – 574 .
   Google Scholar
• WHO Informal Working Group on Echinococcosis . 1996 . Guidelines for treatment of cystic alveolar echinococcosis in humans . Bull. World Health Organ. , 74 : 231 – 242 .
   Google Scholar
• Misra , P. K. , Kumar , A. , Agarwal , U. and Jagota , S. C. 1995 . A comparative clinical trial of albendazole vs. metronidazole in giardiasis . Indian Pediatr. , 32 : 291 – 294 .
   Google Scholar
• Lecuit , N. , Oksenhendler , E. and Sarfati , C. 1994 . The use of albendazole for disseminated microsporidian infection in patients with AIDS . Clin. Infect. Dis. , 19 : 332 – 333 .
   Google Scholar
• Lopez-Garcia , M. L. , Torrado-Duran , S. , Torrado-Duran , J. , Martinez , A. R. and Bolas , F. 1997 . Albendazole versus ricobendazole against enteral and parenteral stages of Trichinella spiralis in mice . Int. J. Parasitol. , 27 : 781 – 785 .
   Google Scholar
• Keramidas , D. , Mavridis , G. , Soutis , M. and Passalidis , A. 2004 . Medical treatment of pulmonary hydatidosis: Complications and surgical management . Pediatr. Surg. Int. , 19 : 774 – 776 .
   Google Scholar
• Del Brutto , O. H. , Sotelo , I. and Raman , G. C. 1993 . Therapy for neurocysticercosis: A reappraisal . Clin. Infect. Dis. , 17 : 730 – 733 .
   Google Scholar
• Gil Grande , L. A. , Rodriguez-Caabeiro , F. , Prieto , J. G. , Sánchez-Ruano , J. J. and Brasa , C. 1993 . Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease . Lancet , 342 : 1269 – 1272 .
   Google Scholar
• Van Nieuwkerk , K. M. J. , Veenstra , J. , Wassenaar , R. P. , Blaauwgeers , H. L. , Geraedts , A. A. and Kroes , H. 1993 . Pancreatitis causes by rupture of liver hydatid cyst . Eur. J. Gastroenterol. Hepatol. , 5 : 563 – 565 .
   Google Scholar
• Yasawy , M. I. , ALKarawi , M. A. and Are , M. 1993 . Combination of praziquantel and albendazole in the treatment of hydatid disease . Trop. Med. Parasitol. , 44 : 192 – 195 .
   Google Scholar
• Amidon , G. L. , Lennernas , H. , Shah , V. P. and Crison , J. R. 1995 . A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability . Pharm. Res. , 12 : 413 – 420 .
   Google Scholar
• Jung , H. , Medina , L. , Garcia , L. , Fuentes , I. and Esparza , R. M. 1998 . Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite, albendazole sulphoxide . J. Pharm. Pharmacol. , 50 : 43 – 48 .
   Google Scholar
• Torrado , S. S. , Lopez , M. L. , Torrado , G. , Bolas , G. , Torrado , S. and Cadorniga , R. 1997 . A novel formulation of albendazole solution: Oral bioavailability and efficacy evaluation . Int. J. Pharm. , 156 : 181 – 187 .
   Google Scholar
• Torrado , S. , Torrado , S. , Torrado , J. J. and Cadorniga , R. 1996 . Preparation, dissolution and characterization of albendazole solid dispersions . Int. J. Pharm. , 140 : 247 – 250 .
   Google Scholar
• Jacobs , C. , Kayser , O. and Müller , R. H. 2000 . Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide . Int. J. Pharm. , 196 : 161 – 164 .
   Google Scholar
• Kayser , O. , Olbrich , C. , Yardley , V. , Kiderlen , A. F. and Croft , S. L. 2003 . Formulation of amphotericin B as nanosuspension for oral administration . Int. J. Pharm. , 254 : 73 – 75 .
   Google Scholar
• Ravichandran , R. 2009 . Nanoparticles in drug delivery: Potential green nanobiomedicine applications . International Journal of Green Nanotechnology: Biomedicine , 1 ( 2 ) : B108 – B130 .
   Google Scholar
• Ravichandran , R. 2009 . Nanotechnology-based drug delivery systems . NanoBiotechnology , 5 ( 1 ) : 17 – 33 .
   Google Scholar
• Chen , X. , Young , T. J. , Sarkari , M. , Williams , R. O. and Johnston , K. P. 2002 . Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution . Int. J. Pharm. , 242 : 3 – 14 .
   Google Scholar
• Muller , R. H. , Jacobs , C. and Kayser , O. 2001 . Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future . Adv. Drug Deliv. Rev. , 47 : 3 – 19 .
   Google Scholar
• Weder , H. G. and van Hoogevest , P. 1998 . Nanosuspensions for Intravenous Administration , U.S. Patent No. 5726164
   Google Scholar
• Müller , R. H. and Jacobs , C. 2002 . Buparvaquone mucoadhesive nanosuspensions: Preparation, optimisation and long-term stability . Int. J. Pharm. , 237 : 151 – 161 .
   Google Scholar
• Rabinow , B. E. 2004 . Nanosuspensions in drug delivery . Nat. Rev. Drug. Discov. , 3 : 785 – 796 .
   Google Scholar
• Keck , C. M. and Muller , R. H. 2006 . Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization . Eur. J. Pharm. Biopharm. , 62 ( 1 ) : 3 – 16 .
   Google Scholar
• Liversidge , G. G. and Cundy , K. C. 1995 . Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs . Int. J. Pharm. , 125 : 91 – 97 .
   Google Scholar
• Jinno , J. , Naoki , K. , Miyake , M. , Yamada , K. , Mukia , T. , Odomi , M. , Togu-chi , H. , Liversidge , G. G. , Higaki , K. and Kimura , T. 2006 . Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs . J. Contr. Release , 111 : 56 – 64 .
   Google Scholar
• Liversidge , G. G. and Conzentino , P. 1995 . Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats . Int. J. Pharm. , 125 : 309 – 313 .
   Google Scholar
• Yamasani , M. R. , Mittapalli , P. K. and Shashank , A. 2008 . Formulation of nanosuspensions of albendazole for oral administration . Current Nanoscience , 4 ( 1 ) : 53 – 58 .
   Google Scholar
• Mittapalli , P. K. , Yamasani , M. R. and Shashank , A. 2007 . Improved bioavailability of albendazole following oral administration of nanosuspension in rats . Current Nanoscience , 3 ( 2 ) : 191 – 194 .
   Google Scholar
• Ravichandran , R. 2010 . Preparation and characterization of albendazole nanosuspensions for oral delivery . International Journal of Green Nanotechnology: Biomedicine , 2 ( 1 ) : B1 – B24 .
   Google Scholar
• Ravichandran , R. 2010 . In vivo pharmacokinetic studies of albendazole nanoparticulate oral formulations for improved bioavailability . International Journal of Green Nanotechnology: Biomedicine , 2 ( 1 ) : B46 – B53 .
   Google Scholar
• Balasubramaniam , J. 2008 . Effect of superdisintegrants on dissolution of cationic drugs . Dissolution Technologies , 12 : 18 – 25 .
   Google Scholar
• United States Pharmacopoeia Conventional . The United States Pharmacopoeia , 24th rev. ed. , Rockville , MD : The United States Pharmacopoeia Conventional Inc. .
   Google Scholar
• Noyes , A. A. and Whitney , W. R. 1987 . The rate of solution of solid substances in their own solutions . J. Am. Chem. Soc. , 19 : 930 – 934 .
   Google Scholar
• Muller , R. H. , Jacobs , C. and Kayser , O. 2000 . “ Nanosuspensions for the formulation of poorly soluble drugs ” . In Pharmaceutical Emulsions and Suspensions , Edited by: Nielloud , F. and Marti-Mestres , G. 383 – 407 . New York : Marcel Dekker .
   Google Scholar
• Muller , R. H. and Akkar , A. 2004 . “ Drug nanocrystals of poorly soluble drugs ” . In Encyclopedia of Nanoscience and Nanotechnology , Edited by: Nalwa , H. S. 627 – 638 . Los Angeles : American Scientific Publishers .
   Google Scholar
• Takano , R. 2008 . Rate-limiting steps of oral absorption for poorly water soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation . Pharm. Res. , 25 ( 10 ) : 2334 – 2344 .
   Google Scholar
• Hintz , R. J. and Johnson , K. C. 1989 . The effect of particle size distribution on dissolution rate and oral absorption . Int. J. Pharm. , 51 : 9 – 17 .
   Google Scholar
• Keck , C. , Fichtinger , A. , Viernstein , H. and Müller , R. 2004 . “ Oral drug nanocrystals—Effect of potential aggregation on bioavailability ” . Baltimore : AAPS . Available online at: http://www.aapsj.org/abstracts/AM_2004/AAPS2004-002746.pdf
   Google Scholar
• Nakarani , M. , Patel , P. , Patel , J. , Patel , P. , Murthy , R. S.R. and Vaghani , S. S. 2010 . Cyclosporin A-nanosuspension: Formulation. Characterization and in vivo comparison with a marketed formulation . SciPharm. , 78 : 345 – 361 .
   Google Scholar